Foteinou Panagiota T, Calvano Steve E, Lowry Stephen F, Androulakis Ioannis P
Biomedical Engineering, Rutgers University, Piscataway, New Jersey, United States of America.
PLoS One. 2009;4(3):e4706. doi: 10.1371/journal.pone.0004706. Epub 2009 Mar 10.
During the onset of an inflammatory response signaling pathways are activated for "translating" extracellular signals into intracellular responses converging to the activation of nuclear factor (NF)-kB, a central transcription factor in driving the inflammatory response. An inadequate control of its transcriptional activity is associated with the culmination of a hyper-inflammatory response making it a desired therapeutic target. Predicated upon the nature of the response, a systems level analysis might provide rational leads for the development of strategies that promote the resolution of the response.
A physicochemical host response model is proposed to integrate biological information in the form of kinetic rules and signaling cascades with pharmacokinetic models of drug action for the modulation of the response. The unifying hypothesis is that the response is triggered by the activation of the NFkB signaling module and corticosteroids serve as a template for assessing anti-inflammatory strategies. The proposed in silico model is evaluated through its ability to predict and modulate uncontrolled responses. The pre-exposure of the system to hypercortisolemia, i.e. 6 hr before or simultaneously with the infectious challenge "reprograms" the dynamics of the host towards a balanced inflammatory response. However, if such an intervention occurs long before the inflammatory insult a symptomatic effect is observed instead of a protective relief while a steroid infusion after inducing inflammation requires much higher drug doses.
We propose a reversed engineered inflammation model that seeks to describe how the system responds to a multitude of external signals. Timing of intervention and dosage regimes appears to be key determinants for the protective or symptomatic effect of exogenous corticosteroids. Such results lie in qualitative agreement with in vivo human studies exposed both to LPS and corticosteroids under various time intervals thus improving our understanding of how interacting modules generate a behavior.
在炎症反应开始时,信号通路被激活,用于将细胞外信号“转化”为细胞内反应,这些反应汇聚到核因子(NF)-κB的激活,NF-κB是驱动炎症反应的核心转录因子。对其转录活性的控制不足与过度炎症反应的 culmination 相关,使其成为一个理想的治疗靶点。基于反应的性质,系统水平的分析可能为促进反应消退的策略开发提供合理线索。
提出了一种物理化学宿主反应模型,以将动力学规则和信号级联形式的生物学信息与药物作用的药代动力学模型整合,用于调节反应。统一假设是反应由NFκB信号模块的激活触发,皮质类固醇作为评估抗炎策略的模板。通过其预测和调节失控反应的能力来评估所提出的计算机模型。系统在高皮质醇血症预暴露,即在感染性挑战前6小时或同时进行,会使宿主动力学“重新编程”为平衡的炎症反应。然而,如果这种干预在炎症损伤之前很久就发生,则会观察到症状性效应而非保护性缓解,而在诱导炎症后进行类固醇输注则需要更高的药物剂量。
我们提出了一种反向工程炎症模型,旨在描述系统如何对多种外部信号做出反应。干预时机和剂量方案似乎是外源性皮质类固醇产生保护或症状性效应的关键决定因素。这些结果与在不同时间间隔下暴露于LPS和皮质类固醇的体内人体研究在定性上一致,从而增进了我们对相互作用模块如何产生一种行为的理解。